Julia G Butchko Net Worth & Insider Trades
Julia G Butchko - Chief Dev. & Tech. Officer, Immunovant, Inc
What is Julia G Butchko's Net Worth?
The current estimated net worth of Immunovant, Inc's Chief Dev. & Tech. Officer, Julia G Butchko, is estimated to be about $1.5M . Julia G Butchko owns about 331,419 units of Immunovant, Inc common stock. In the last 4 years at Immunovant, Inc, Julia G Butchko has sold an estimated value of $1.48M worth.
What is Julia G Butchko's Past Insider Trading?
Julia G Butchko's largest purchase order was 5,000 units , worth over $190.85K on September 15, 2020. Julia G Butchko's largest sale order was 60,490 units , worth over $1.02M on January 13, 2023. In total, Julia G Butchko has made about 17 transactions over 4 years of their time at Immunovant, Inc. Julia G Butchko usually trades in September, with the busiest year in 2022.
Julia G Butchko
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Julia G Butchko's Salary in 2020?
As Chief Dev. & Tech. Officer of Immunovant, Inc, Julia G Butchko has a total base salary of $372,000 . Julia G Butchko received compensation valued at about $7,842,357 in 2020 after becoming Chief Dev. & Tech. Officer. The vast majority of their compensation came in the form of a bonus of $148,800 , stock awards of $926,500 , option awards of $6,384,856 , other compensation of $10,201 .
What is Julia G Butchko's' Mailing Address?
- Mailing address is 320 W 37th Street, 3rd Floor New York NY 10016 NY
Immunovant, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Peter Salzmann, M.D., M.B.A. | 2020 | $ 567,000 | $ 311,850 | $ 3,252,500 | $ 11,104,950 | $ | $ 139,004 | $ 15,375,304 |
| Peter Salzmann, M.D., M.B.A. | 2019 | $361,010 | $500,000 | - | $7,721,344 | $224,480 | - | $8,806,834 |
| Pamela Yanchik Connealy, M.B.A. | 2020 | $393,000 | $157,200 | $785,400 | $4,258,363 | - | $8,742 | $5,602,705 |
| Pamela Yanchik Connealy, M.B.A. | 2019 | $147,618 | - | - | $2,437,762 | $61,233 | $129,321 | $2,775,934 |
| Julia G. Butchko, Ph.D. | 2020 | $372,000 | $148,800 | $926,500 | $6,384,856 | - | $10,201 | $7,842,357 |
| Michael J. Elliott, | 2020 | $242,425 | $96,000 | $1,659,200 | $14,229,311 | - | $9,695 | $16,236,631 |
| Rita Jain, M.D. | 2020 | $101,137 | $38,526 | $2,703,005 | $10,666,997 | - | $3,319 | $13,512,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1764013/000176401321000083/imvt-20210331defproxy.htm
What are Immunovant, Inc's Past Insider Trades?
Immunovant, Inc's most recent insider trade came on February 3, 2023 by William L Macias who sold 537 units worth $9.79K . In the last 3 years, insiders at Immunovant, Inc have sold an estimated value of $4.22M and bought an estimated value of $399.92M worth of shares. Insider trading is most common in August, with the busiest year in 2022. The most active traders at the company are Julia G Butchko, Chief Dev. & Tech. Officer, Peter Salzmann, Chief Executive Officer, and William L Macias, Chief Medical Officer .
Immunovant, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||